(CPIX, EXLS, EXE) CRWENewswire Stocks to Watch
In the Q4 2011, ExlService Holdings Inc - EXLS - achieved record revenues of $102.6M, a 46.5% increase year over year. Cumberland Pharmaceuticals Inc - CPIX - reported that it has entered into an exclusive agreement with China’s Harbin Gloria Pharmaceuticals for the commercialization of Acetadote (acetylcysteine) and Caldolor (ibuprofen) Injection. According to The company, In exchange for the license to the product, Cumberland will receive upfront and milestone licensing payments, as well as royalties on future sales of both drugs. For the Q4 of 2011, Crexendo Inc - EXE - posted Net income of $459,000, compared to a net loss of $2,405,000 in the same period the prior year

*****

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

ユーザー：karmastock
再生時間：00:01:26
投稿日時：12/02/29 15:19
カテゴリ：ビジネス全般 
タグ： EXLS  CPIX  EXE  Amex:EXE  Nasdaq:CPIX  Nasdaq:EXLS 

[ 前ページへ戻る ]